Voloridge Investment Management Llc decreased Bhp Billiton Ltd (BHP) stake by 24.7% reported in 2017Q3 SEC filing. Voloridge Investment Management Llc sold 104,627 shares as Bhp Billiton Ltd (BHP)’s stock declined 8.86%. The Voloridge Investment Management Llc holds 318,880 shares with $12.92M value, down from 423,507 last quarter. Bhp Billiton Ltd now has $136.49B valuation. The stock increased 2.05% or $1.02 during the last trading session, reaching $50.69. About 3.85M shares traded or 66.63% up from the average. BHP Billiton Limited (NYSE:BHP) has risen 34.32% since January 13, 2017 and is uptrending. It has outperformed by 17.62% the S&P500.
Burney Co decreased Abbvie Inc (ABBV) stake by 3.56% reported in 2017Q3 SEC filing. Burney Co sold 5,599 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Burney Co holds 151,619 shares with $13.49 million value, down from 157,218 last quarter. Abbvie Inc now has $160.19 billion valuation. The stock increased 1.08% or $1.07 during the last trading session, reaching $100.34. About 4.37M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 13, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.
Since July 31, 2017, it had 0 insider buys, and 8 insider sales for $45.57 million activity. On Monday, August 7 GONZALEZ RICHARD A sold $13.71 million worth of AbbVie Inc. (NYSE:ABBV) or 193,131 shares. The insider SALEKI-GERHARDT AZITA sold $705,655. $1.66M worth of stock was sold by Gosebruch Henry O on Monday, October 30. The insider Schumacher Laura J sold 145,510 shares worth $14.07 million. 87,040 shares were sold by RICHMOND TIMOTHY J., worth $8.57 million. 6,699 AbbVie Inc. (NYSE:ABBV) shares with value of $589,512 were sold by Michael Robert A..
Burney Co increased Comcast Corp (NASDAQ:CMCSA) stake by 20,098 shares to 459,283 valued at $17.37M in 2017Q3. It also upped Vanguard Reit Index Etf (VNQ) stake by 4,344 shares and now owns 11,529 shares. Ubiquiti Networks Inc (NASDAQ:UBNT) was raised too.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 70 analyst reports since July 21, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Hold” rating and $6 target in Monday, July 17 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Thursday, May 25. Citigroup upgraded the shares of ABBV in report on Monday, September 28 to “” rating. Leerink Swann initiated AbbVie Inc. (NYSE:ABBV) rating on Tuesday, October 18. Leerink Swann has “Mkt Perform” rating and $70 target. William Blair initiated AbbVie Inc. (NYSE:ABBV) on Friday, February 5 with “Outperform” rating. Jefferies maintained the shares of ABBV in report on Friday, August 18 with “Buy” rating. Jefferies maintained the stock with “Buy” rating in Monday, May 29 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Neutral” rating by Citigroup on Monday, November 28. As per Tuesday, December 1, the company rating was downgraded by Barclays Capital. The firm has “Buy” rating given on Monday, July 17 by Jefferies.
Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 17.54 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.
Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It worsened, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Schwartz Invest Counsel holds 0.01% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 2,400 shares. Auxier Asset Mgmt reported 0.41% stake. Cincinnati Specialty Underwriters Insur Co invested 2.12% of its portfolio in AbbVie Inc. (NYSE:ABBV). Idaho-based Selway Asset has invested 1.4% in AbbVie Inc. (NYSE:ABBV). Chase Counsel has 2,310 shares for 0.11% of their portfolio. Ingalls & Snyder Ltd Com reported 0.55% in AbbVie Inc. (NYSE:ABBV). Prentiss Smith holds 0.37% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 6,950 shares. Macnealy Hoover Investment Management Inc holds 25,563 shares. Lvw Advsrs Lc invested 1.34% in AbbVie Inc. (NYSE:ABBV). Hartford Financial Mngmt reported 160 shares or 0.01% of all its holdings. Renaissance Tech reported 0.15% of its portfolio in AbbVie Inc. (NYSE:ABBV). Sfmg Ltd Liability reported 3,675 shares. Jennison Assocs Llc accumulated 6.13M shares. Perigon Wealth accumulated 11,823 shares. 1.38M were reported by Cincinnati Insur.
Voloridge Investment Management Llc increased Ishares Silver Trust (SLV) stake by 47,129 shares to 534,633 valued at $8.42M in 2017Q3. It also upped Sociedad Quimica Minera De C (NYSE:SQM) stake by 128,060 shares and now owns 146,071 shares. Ryanair Hldgs Plc was raised too.
Among 25 analysts covering BHP Billiton Limited (ADR) (NYSE:BHP), 9 have Buy rating, 5 Sell and 11 Hold. Therefore 36% are positive. BHP Billiton Limited (ADR) had 54 analyst reports since July 22, 2015 according to SRatingsIntel. Clarkson Platou downgraded the stock to “Neutral” rating in Tuesday, November 17 report. UBS downgraded the shares of BHP in report on Tuesday, October 11 to “Neutral” rating. The firm earned “Buy” rating on Friday, April 7 by CLSA. The firm earned “Hold” rating on Wednesday, March 9 by Argus Research. Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, December 7 report. Cowen & Co maintained BHP Billiton Limited (NYSE:BHP) rating on Wednesday, January 27. Cowen & Co has “Market Perform” rating and $25 target. Deutsche Bank upgraded the shares of BHP in report on Wednesday, July 5 to “Buy” rating. On Thursday, March 17 the stock rating was downgraded by Nomura to “Neutral”. The company was upgraded on Monday, September 14 by Jefferies. The firm has “Hold” rating given on Friday, October 2 by Societe Generale.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.